Colorectal cancer (CRC) is the third most frequently occurring tumor in the human
population. CRCs are usually adenocarcinomatous and originate as a polyp on the inner …

Background: Carcinoembryonic Antigen (CEA) is a recommended prognostic marker in
Colorectal Cancer (CRC) for tumor diagnosis and monitoring response to therapy. High CEA …

The advent and subsequent development of nanotechnology in the past few years have
been a boon to the healthcare industry and especially in cancer therapy. Cancer, as it is …

Colorectal cancer (CRC) is one of the deadliest diseases worldwide due to a lack of early
detection methods and appropriate drug delivery strategies. Conventional imaging …

Colorectal cancer (CRC) is highly prevalent worldwide, and despite notable progress in
treatment still leads to significant morbidity and mortality. The use of nanoparticles as a drug …

Colon cancer is an adenocarcinoma, which subsequently develops into malignant tumors, if
not treated properly. The current colon cancer therapy mainly revolves around …

The diagnosis of gastrointestinal (GI) diseases currently relies primarily on invasive
procedures like digestive endoscopy. However, these procedures can cause discomfort …

In vitro detection technique Raman spectroscopy (Rs), in one number times another Rs
based expert ways of art and so on, are useful instruments for cancer discovery. top gave …

Mass testing for the diagnosis of COVID-19 has been hampered in many countries owing to
the high cost of genetic material detection. This study reports on a low-cost immunoassay for …

The global incidence of colorectal cancer (CRC) is 1.3 million cases. It is the third most
frequent cancer in males and females. Most CRCs are adenocarcinomas and often begin as …